INTRODUCTION
============

Growth hormone (GH) is a peptide hormone secreted from the pituitary gland that controls normal postnatal growth and regulates physiological processes including carbohydrate and lipid metabolism ([@b42-ajas-27-1-147-17]; [@b46-ajas-27-1-147-17]). GH also stimulates liver to release Insulin-like growth factor-I (IGF-I), which in turn controls growth and metabolism as well. In addition, GH antagonizes insulin action in several tissues and regulates a nutrient partitioning effect. GH activity can be regulated at the level of growth hormone receptor (GHR) or intracellular signal transduction and with catabolic situations such as parturition, malnutrition, infection and disease occurrence may lead to a state of GH resistance ([@b41-ajas-27-1-147-17]; [@b45-ajas-27-1-147-17]; [@b67-ajas-27-1-147-17]; [@b37-ajas-27-1-147-17]). GH resistance is characterized by reduced circulating IGF-I despite unchanged or increased plasma GH level. In circulation, most of the IGFs exist in ternary complexes composed of IGF-I or -II, IGF-binding protein (IGFBP)-3 or -5 and acid labile subunit (ALS) ([@b66-ajas-27-1-147-17]; [@b4-ajas-27-1-147-17]; [@b58-ajas-27-1-147-17]). ALS is synthesized primarily in liver in a GH-dependent manner ([@b51-ajas-27-1-147-17]; [@b64-ajas-27-1-147-17]). Incorporation of free IGF-I in these ternary complexes extends its half-life from minutes to over 15 h ([@b51-ajas-27-1-147-17]; [@b64-ajas-27-1-147-17]). A complete understanding of growth and metabolism involves an appreciation of GH, IGF-I, IGFBPs, ALS and insulin due to their collective action on animals. In this review, I will address modulation of somatotropic axis during physiological and metabolic adaptations. In addition, implications for GHR will be explored for understanding modulation of GH and IGF action.

GROWTH HORMONE (GH)
===================

GH is synthesized and stored by somatotroph cells within the anterior pituitary gland. GH contains approximately 200 amino acids with two disulfide bonds. The amino acid identity between bovine and ovine GH, or bovine and porcine GH is 99% and 90%, respectively. Two hypothalamic peptides, GH-releasing hormone (GHRH) and somatostatin (SS), regulate GH synthesis and secretion. Binding of GHRH to its G-protein coupled receptors increases cellular cAMP level ([@b47-ajas-27-1-147-17]) and GH secretion. SS inhibits GH release, primarily by affecting the timing and amplitude of GH secretion rather than its synthesis ([@b11-ajas-27-1-147-17]). Another class of synthetic molecules called GH-releasing peptides (GHRPs) is able to stimulate GH release through activation of the GH secretagogue receptor (GHS-R) ([@b10-ajas-27-1-147-17]). The endogenous ligand for GHS-R appears to be ghrelin, a 28-residue peptide expressed at high levels in stomach as well as lower levels in the hypothalamus ([@b40-ajas-27-1-147-17]). Therefore, GH secretion can be regulated by both hypothalamic and peripheral signals Release of GH from pituitary gland is not constant over time, but rather is intermittent, or pulsatile. Species differ both in the temporal profiles of circulating GH concentration. Sex differences in the pulsatile profile of circulating GH and in mean GH concentrations are likely to contribute to sex differences in growth and other response to GH ([@b22-ajas-27-1-147-17]).

GROWTH HORMONE RECEPTOR (GHR) AND ITS INTRACELLULAR SIGNALING
=============================================================

In all species, the GHR is a member of the class 1 hematopoietin receptor superfamily ([@b61-ajas-27-1-147-17]; [@b41-ajas-27-1-147-17]). The GHR consists of a ligand binding extracellular domain (N-terminus), a hydrophobic transmembrane domain, and a large intracellular domain (C-terminus). In cattle, there are three promoters, termed P1, P2, and P3 that transcribe three major classes of GHR transcripts, referred to as GHR1A, GHR1B, and GHR1C, respectively ([@b25-ajas-27-1-147-17]; [@b57-ajas-27-1-147-17]; [@b32-ajas-27-1-147-17]). The mRNA variants are produced by the alternative splicing of exon 1A, 1B or 1C onto a core transcript containing exon 2 to 10. All GHRs are identical proteins because the GHR protein is encoded in exon 2 to 10 of the mRNA ([@b18-ajas-27-1-147-17]). The GHR1A is expressed exclusively in liver where it accounts for \~50% of total hepatic GHR transcripts ([@b39-ajas-27-1-147-17]; [@b30-ajas-27-1-147-17]; [@b45-ajas-27-1-147-17]). The P1 promoter is up-regulated by the hepatic nuclear factor 4, HNF4 ([@b29-ajas-27-1-147-17]) and the signal transducer and activator of transcription 5, STAT5 ([@b33-ajas-27-1-147-17]). The P2 promoter transcribes GHR1B transcripts in a variety of tissues. GHR1B transcripts accounts for \~35% of total GHR transcripts in liver and \~70% in other tissues ([@b24-ajas-27-1-147-17]; [@b30-ajas-27-1-147-17]). The ubiquitous transcription factor Sp1 is required for efficient activity of the P2 promoter ([@b32-ajas-27-1-147-17]). The GHR1C transcript is also produced in a variety of tissues by the P3 promoter. GHR1C transcript accounts for \~15% of total GHR in liver and \~30% in other tissues ([@b31-ajas-27-1-147-17]; [@b32-ajas-27-1-147-17]).

The working model of GH action involves numerous multi-step signal transduction cascades and has been described in the reviews ([@b26-ajas-27-1-147-17]; Kopchick and Andry, 2001; [@b67-ajas-27-1-147-17]). GHR dimerization is a key requirement for receptor activation and leads to the activation of Janus kinase 2 (JAK2). JAK2 is a tyrosine kinase and phosphorylates tyrosine residue on itself and on the GHR. Thus, phosphorylated JAK2 and GHR provide multiple sites for signal molecules to bind. There are four major signaling pathway mediating GH actions have been studied: i) STAT signaling pathway, ii) mitogen-activated protein kinase (MAPK) pathway, iii) insulin receptor substrate (IRS) pathway, iv) phospholipase Cγ (PLCγ) pathway. These pathways are characterized by multiple points of intersection and convergence. In most physiological situations, there is an evidence of cross-talk between these pathways. Among these pathways, STAT is known to be the major pathway for regulation of IGF-I and ALS by GH actions. GH can activate four STATs, i.e. STAT1, 3, 5a, and 5b. JAK2 phosphorylates STATs on a single tyrosine residue, and then STATs are dimerized via their SH2 domain. Dimerized STATs translocate into the nucleus where they bind to *cis*-elements in the promoter regions of target genes. STAT5 has been implicated in the GH-regulation of IGF-I gene transcription. IGF-I expression is STAT5b-dependent ([@b17-ajas-27-1-147-17]) and a functional STAT5 response element on IGF-I gene has been identified ([@b65-ajas-27-1-147-17]; [@b64-ajas-27-1-147-17]).

PROPERTIES OF IGF-I TERNARY COMPLEXES
=====================================

The IGF system contains two ligands, named IGF-I and -II ([@b16-ajas-27-1-147-17]). Only IGF-I will be discussed here because it is generally recognized that only IGF-I is correlated with postnatal growth and metabolism, and is regulated by GH ([@b42-ajas-27-1-147-17]). Although structurally similar to insulin, IGF-I differs with respect to its sites of origin, mode of action and circulating forms. Unlike the exclusive secretion of insulin by pancreatic β-cells, IGF-I is secreted by peripheral tissues in addition to its primary release form liver. After birth, IGF-I circulates in blood at high concentrations reflecting mostly hepatic production ([@b42-ajas-27-1-147-17]). Proteins with high affinity for IGFs called the insulin-like growth factor binding proteins (IGFBP) have been identified. Six IGFBPs have been isolated in the human and rat and shown to belong to a single family ([@b53-ajas-27-1-147-17]; [@b34-ajas-27-1-147-17]). The major roles include shuttling IGFs from the circulation to tissues and modulation of IGFs action by controlling their access to specific receptors ([@b34-ajas-27-1-147-17]; [@b20-ajas-27-1-147-17]). In rodents, humans and domestic species, IGFBP-1 and -2 constitute the largest proportion of plasma IGFBPs present during fetal life whereas IGFBP-3 is the predominant circulating IGFBP in the adult ([@b52-ajas-27-1-147-17]; [@b50-ajas-27-1-147-17]). Most of the IGFs in fetal plasma appear at the 40 to 50 kDa ([@b12-ajas-27-1-147-17]). This agrees with circulation of IGF bound to IGFBPs of \~24 to 43 kDa ([@b14-ajas-27-1-147-17]; [@b48-ajas-27-1-147-17]). In plasma of adult animals, however, most of the IGFs are found at 150 kDa. The complex is composed of three units; one molecule of IGF-I or -II, one molecule of IGFBP-3 or IGFBP-5 and one molecule termed the acid-labile subunit (ALS) ([@b4-ajas-27-1-147-17]; [@b5-ajas-27-1-147-17]; [@b6-ajas-27-1-147-17]; [@b58-ajas-27-1-147-17]). Genomic characteristics of the ALS has been identified in sheep, cattle, human, pig and mouse ([@b15-ajas-27-1-147-17]; [@b44-ajas-27-1-147-17]; [@b9-ajas-27-1-147-17]; [@b43-ajas-27-1-147-17]; [@b36-ajas-27-1-147-17]). Three-dimensional structure predicted by computational modeling and rotary shadowing electron microscopy shows that ALS is a donut-shaped structure with negative-charged internal face which is thought to be important for binding with IGFBP-3 and -5 ([@b21-ajas-27-1-147-17]; [@b59-ajas-27-1-147-17]; [@b28-ajas-27-1-147-17]). In cattle, the abundance of ALS mRNA is five-fold in liver than that in lung, small intestine, adipose tissue, kidney and heart, but is almost absent in muscle and brain ([@b36-ajas-27-1-147-17]).

Incorporation of ALS in ternary complexes extends their half-lives from 10 min (free IGFs) or 30 min (IGF-IGFBPs in binary complexes) to over 15 h ([@b66-ajas-27-1-147-17]; [@b58-ajas-27-1-147-17]). This evidence explains that IGFs cross the endothelial barrier when in free form or binary complexes, but are unable to do when in ternary complexes ([@b8-ajas-27-1-147-17]). To understand the functionality and the action of ALS on development and growth, ALS knock-out mice model has been studied ([@b60-ajas-27-1-147-17]). ALS deficient mice show a reduction of circulating IGF-I (62%) and IGFBP-3 (88%), and suffer at 15% growth retardation, but have normal plasma levels of glucose, insulin and GH. GH replacement therapy cannot restore in plasma IGF-I levels and growth ([@b60-ajas-27-1-147-17]). This reflects that the ternary complexes are unable to be formed in ALS deficient mice and without ALS, overall IGF-I effects on development and growth is reduced.

CHANGES IN THE SOMATOTROPIC AXIS
================================

In domestic animals, it is evident that GH stimulates IGF-I synthesis, and that a positive relationship exists between body weight gain and plasma IGF-I ([@b19-ajas-27-1-147-17]; [@b1-ajas-27-1-147-17]; [@b54-ajas-27-1-147-17]). It is also well established that GH inhibits fat deposition and increases fat mobilization [@b27-ajas-27-1-147-17]). In early 1990's, Bauman and Vernon proposed a model of GH action in lactating dairy cows representing undernutrition condition. In this model, GH actions are reduced in liver, limiting IGF-I production and its related anabolic effects ([@b3-ajas-27-1-147-17]). During the periparturient period, Cows in periparturient period are in negative energy balance the feed intake does not meet the total energy demand that increased by \~4-fold during the onset of lactation ([@b7-ajas-27-1-147-17]; [@b2-ajas-27-1-147-17]). Under this condition, key hormones of somatotropic axis, i.e. GH, IGF-I and insulin must coordinate adaptations required for the preservation of metabolic homeostasis ([@b7-ajas-27-1-147-17]). Dairy cows during the parturition suffer a reduction of plasma IGF-I despite elevated plasma GH ([Figures 1](#f1-ajas-27-1-147-17){ref-type="fig"} and [2](#f2-ajas-27-1-147-17){ref-type="fig"}), a condition known as GH resistance. The somatotropic axis becomes uncoupled. Plasma insulin concentrations are low as well ([@b55-ajas-27-1-147-17]). Increased GH stimulates the lipolytic effects (elevated plasma NEFA and glycerol) and associates with adipose tissue mobilization. GH also stimulates hepatic gluconeogenesis to meet the energy requirement for mammary lactose synthesis ([@b38-ajas-27-1-147-17]). It is suggested that GH antagonizes insulin-dependent glucose uptake and attenuates the ability of insulin to decrease gluconeogenesis. This insulin resistance conserves glucose for lactose synthesis in mammary gland ([@b23-ajas-27-1-147-17]). Therefore, elevated GH concentration drives nutrient partitioning to facilitate milk production.

The actions of GH are regulated by the GHR. Regarding GHR regulation, hepatic GHR1A transcript of dairy cows changes dramatically before and after partutition ([@b45-ajas-27-1-147-17]; [@b35-ajas-27-1-147-17]). The hepatic abundance of GHR1A transcript is lower on day +3 than on day −35 and returns to late pregnancy value by day +56 ([Figure 3](#f3-ajas-27-1-147-17){ref-type="fig"}). The expression pattern for IGF-I mRNA is similar to GHR1A. The hepatic abundance of GHR protein is also reduced at parturition when GHR1A expression declines, but recovers when GHR1A is normalized. However, plasma IGF-I concentration remain low even though hepatic abundance of the GHR and IGF-I mRNA return to pre-calving value. This might be caused by alternation in IGFBPs and ALS genes, which consequently might affect the plasma IGF-I stability. The abundance profile of ALS mRNA and protein is similar to GHR1A and IGF-I mRNA ([Figure 4](#f4-ajas-27-1-147-17){ref-type="fig"}) ([@b36-ajas-27-1-147-17]). These results suggest that ALS plays little or no role in the persisting plasma IGF-I depression. Thus, IGFBP3 might be the other possible candidate behind the reduced plasma IGF-I level. When analyzed by ligand blotting, IGFBP3 remains low until day +56 after parturition (unpublished data). The regulation of IGFBP3 during the periparturient period needs to be addressed in future studies. As for insulin, plasma insulin concentration declines in a parallel manner with the decrease in plasma IGF-I after parturition. Insulin infusion into early lactating cows increases GHR1A, IGF-I mRNA in liver, GHR in adipose tissues and plasma IGF-I concentration ([@b13-ajas-27-1-147-17]; [@b55-ajas-27-1-147-17]). Thus, insulin plays as a recoupling factor for the somatotropic axis. Furthermore, the abundance of GHR protein in adipose tissue decreases in low-insulin states such as postparturition and undernutrition ([@b55-ajas-27-1-147-17]; [@b56-ajas-27-1-147-17]). The recent studies have been indicated that the single nucleotide polymorphisms (SNPs) in relation with genes of the somatotrophic axis are associated with performance traits in dairy cattle. On the GHR sequences, the allelic substitution of *GHR4.2* in the 5′ non-coding region and F279Y in exon 8 was associated with milk yield (Waters et al., 2010). Further extensive study showed that F279Y on the GHR was significantly associated with milk fat and protein as well ([@b62-ajas-27-1-147-17]). Variation in the GH (one GH SNP, *GH33*) sequence was associated with milk yield, fat and protein contents. A single IGF-I SNP, *IGFi3* was significantly associated with milk yield ([@b49-ajas-27-1-147-17]).

CONCLUSIONS
===========

The somatotropic axis plays a pivotal role in growth and metabolism. GH, IGF-I complexes and insulin are key hormones that coordinate physiological adaptations to preserve metabolic homeostasis. The actions of GH are mediated by the activity and abundance of GHR and its intracellular signaling. In ruminant, catabolic states (undernutrition and parturition) modulate the abundance of hepatic GHR and its downstream target genes such as IGF-I and ALS. However, the abundance of hepatic JAK2 and STAT5 proteins are almost invariant during the periparturient period (unpublished data). Future studies will be needed to measure activation/phosphorylation of hepatic JAK2, STAT5 or other intracellular protein as an index for GH responsiveness. Overall, understanding the mechanisms of somatotropic axis modulation during the periparturient period by key hormones may lead to improvement for dairy production.

![Profiles of plasma IGF-I, dry matter intake, and net energy balance during the transition from pregnancy to lactation in multiparous dairy cows. Cows (n = 9) were studied in the period from d 21 prepartum to d 8 postpartum. The day of parturition is denoted by the dashed vertical line (adapted from [@b55-ajas-27-1-147-17]).](ajas-27-1-147-17f1){#f1-ajas-27-1-147-17}

![Profiles of plasma GH and insulin during the transition from pregnancy to lactation in multiparous dairy cows. Cows (n = 9) were studied in the period from d 21 prepartum to d 8 postpartum. The day of parturition is denoted by the dashed vertical line (adapted from [@b55-ajas-27-1-147-17]).](ajas-27-1-147-17f2){#f2-ajas-27-1-147-17}

![The abundance of hepatic IGF-I mRNA, GHR1A mRNA and GHR protein during the periparturient period. (A) IGF-I, GHR1A and GHR~other~ mRNA were analyzed by RPA. (B) Total cellular proteins (total) and membrane protein (membrane) were analyzed by western blotting for the abundance of the GHR (adapted from [@b35-ajas-27-1-147-17]).](ajas-27-1-147-17f3){#f3-ajas-27-1-147-17}

![Profile of plasma ALS abundance during the periparturient period. Four multiparous dairy cows were studied during the period between day −35 and +56. (A) Plasma IGF-I concentration was measured by RIA. (B) Plasma ALs was measured by western blotting. The effect of time was partitioned into linear (L), quadratic (Q) and cubic (C) contrasts (adapted from [@b36-ajas-27-1-147-17]).](ajas-27-1-147-17f4){#f4-ajas-27-1-147-17}
